Organogenesis Holdings Inc (ORGO)

May 01, 2026

ORGO Price Today: Organogenesis Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

May 01, 2026

Apr 30, 2026

[ARS] Organogenesis Holdings Inc. SEC Filing - Stock Titan

Apr 30, 2026

Apr 30, 2026

Organogenesis (NASDAQ: ORGO) details 2026 virtual meeting, pay and audit votes - Stock Titan

Apr 30, 2026

Apr 30, 2026

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® - Orthopedics This Week

Apr 30, 2026

Apr 30, 2026

Organogenesis (ORGO) Projected to Post Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 29, 2026

Organogenesis completes biologics license application for knee OA By Investing.com - Investing.com India

Apr 29, 2026

Apr 29, 2026

Organogenesis completes biologics license application for knee OA - Investing.com UK

Apr 29, 2026

Apr 28, 2026

Organogenesis Holdings Inc. Completes Biologics License Application Submission for ReNu® to Treat Knee Osteoarthritis - Quiver Quantitative

Apr 28, 2026

Apr 28, 2026

31.1M Americans have knee OA; Organogenesis sends ReNu to FDA - Stock Titan

Apr 28, 2026

Apr 28, 2026

What's going on with Organogenesis stock on Wednesday? - MSN

Apr 28, 2026

Apr 28, 2026

Organogenesis (NASDAQ:ORGO) Trading Up 1.7%Time to Buy? - MarketBeat

Apr 28, 2026

Apr 27, 2026

Organogenesis rises as PuraPlyAM succeeds in diabetic foot ulcers - MSN

Apr 27, 2026

Apr 27, 2026

ORGO stock rallies after hours on clearing regulatory pathway for pain relief treatment - MSN

Apr 27, 2026

Apr 26, 2026

Organogenesis shares jump 20% following positive clinical trial results - MSN

Apr 26, 2026

Apr 24, 2026

Organogenesis (ORGO) CCO exercises option, now holds 900,682 shares - Stock Titan

Apr 24, 2026

Apr 24, 2026

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence - GlobeNewswire Inc.

Apr 24, 2026

Apr 23, 2026

Organogenesis Holdings Q3 2025 Earnings Preview - MSN

Apr 23, 2026

Apr 20, 2026

Organogenesis Holdings (ORGO) Stock Dark Pool Activity (Trend Weakens) 2026-04-20Shared Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La

Apr 20, 2026

Apr 17, 2026

Organogenesis Holdings Inc. (ORGO): Investor Outlook With A 213% Potential Upside - DirectorsTalk Interviews

Apr 17, 2026

Apr 15, 2026

Organogenesis Holdings, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire

Apr 15, 2026

Apr 13, 2026

3 Penny Stocks With Market Caps Under $400M To Consider - simplywall.st

Apr 13, 2026

Apr 13, 2026

Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens - The Chronicle-Journal

Apr 13, 2026

Apr 10, 2026

Options Flow: Will Organogenesis Holdings Inc benefit from rate cuts2026 EndofMonth & Stepwise Trade Execution Plans - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

720p-h264Dailyhunt - Dailyhunt

Apr 10, 2026

Apr 09, 2026

What's Going On With Organogenesis Stock On Wednesday? - Sahm

Apr 09, 2026

Apr 07, 2026

Organogenesis: Clinical Win De-Risks 2026, Recovery In Sight (NASDAQ:ORGO) - Seeking Alpha

Apr 07, 2026

Apr 07, 2026

Organogenesis stock rockets after diabetic foot ulcer trial posts statistically significant win - MSN

Apr 07, 2026

Apr 07, 2026

PuraPly AM Triumphs in Wound Healing Trial, Paves Way for New Successes - StocksToTrade

Apr 07, 2026

Apr 07, 2026

Organogenesis’ Clinical Trials Propel Stock Amid FDA Progress - timothysykes.com

Apr 07, 2026

Apr 07, 2026

Organogenesis stock surges 20% on trial results By Investing.com - Investing.com Australia

Apr 07, 2026

Apr 07, 2026

Organogenesis Stock Rockets After Diabetic Foot Ulcer Trial Posts Statistically Significant Win - Benzinga

Apr 07, 2026

Apr 07, 2026

Organogenesis stock surges 20% on trial results - Investing.com

Apr 07, 2026